DBV Technologies (DBVT) Free Cash Flow Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -151.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -151.27% |
| Dec 31, 2025 | -193.11% |
| Sep 30, 2025 | -42.44% |
| Jun 30, 2025 | 5.28% |
| Mar 31, 2025 | 45.32% |
| Dec 31, 2024 | 13.61% |
| Sep 30, 2024 | -16.46% |
| Jun 30, 2024 | -39.23% |
| Mar 31, 2024 | -71.95% |
| Dec 31, 2023 | 41.26% |
| Sep 30, 2023 | 3.91% |
| Jun 30, 2023 | -145.20% |
| Mar 31, 2023 | -1,198.14% |
| Dec 31, 2022 | -21.30% |
| Sep 30, 2022 | 10.97% |
| Jun 30, 2022 | 65.19% |
| Mar 31, 2022 | 95.56% |
| Dec 31, 2021 | 41.25% |
| Sep 30, 2021 | 45.69% |
| Mar 31, 2021 | 27.94% |
| Dec 31, 2020 | -159.24% |
| Sep 30, 2020 | 63.74% |
| Dec 31, 2019 | 137.59% |
| Sep 30, 2019 | 2.11% |
| Jun 30, 2019 | -9.26% |
| Dec 31, 2018 | -19.43% |
| Dec 31, 2017 | -126.51% |
| Dec 31, 2016 | -308.13% |
| Dec 31, 2015 | -4.21% |